EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium

Ross Hamblin, Athanasios Fountas, Kirstie Lithgow, Paul Benjamin Loughrey, Efstathios Bonanos, Shah Khalid Shinwari, Kirsten Mitchell, Syed Shah, Lydia Grixti, Mike Matheou, Kristina Isand, David S McLaren und 40 weitere

European Journal of Endocrinology · 20.07.2023 · 189 (1) · 87-95

DOI: 10.1093/ejendo/lvad070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 22.06.2023. Verfasst von Ross Hamblin und 51 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, United Kingdom. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma, Hypopituitarism. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The optimal approach to the surveillance of non-functioning pituitary microadenomas (micro-NFPAs) is not clearly established. Our aim was to generate evidence on the natural history of micro-NFPAs to support patient care.

Design

Multi-centre, retrospective, cohort study involving 23 endocrine departments (UK NFPA consortium).

Methods

Clinical, imaging, and hormonal data of micro-NFPA cases between January, 1, 2008 and December, 21, 2021 were analysed.

Results

Data for 459 patients were retrieved [median age at detection 44 years (IQR 31-57)—152 males/307 females]. Four hundred and nineteen patients had more than two magnetic resonance imagings (MRIs) [median imaging monitoring 3.5 years (IQR 1.71-6.1)]. One case developed apoplexy. Cumulative probability of micro-NFPA growth was 7.8% (95% CI, 4.9%-8.1%) and 14.5% (95% CI, 10.2%-18.8%) at 3 and 5 years, respectively, and of reduction 14.1% (95% CI, 10.4%-17.8%) and 21.3% (95% CI, 16.4%-26.2%) at 3 and 5 years, respectively. Median tumour enlargement was 2 mm (IQR 1-3) and 49% of micro-NFPAs that grew became macroadenomas (nearly all >5 mm at detection). Eight (1.9%) patients received surgery (only one had visual compromise with surgery required >3 years after micro-NFPA detection). Sex, age, and size at baseline were not predictors of enlargement/reduction. At the time of detection, 7.2%, 1.7%, and 1.5% patients had secondary hypogonadism, hypothyroidism, and hypoadrenalism, respectively. Two (0.6%) developed hypopituitarism during follow-up (after progression to macroadenoma).

Conclusions

Probability of micro-NFPA growth is low, and the development of new hypopituitarism is rare. Delaying the first follow-up MRI to 3 years and avoiding hormonal re-evaluation in the absence of tumour growth or clinical manifestations is a safe approach for micro-NFPA surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsAdenomaHypopituitarismMaleFemaleHumansAdultMiddle AgedRetrospective StudiesCohort StudiesUnited Kingdom

Stichwörter der Autor:innen

adenomaincidentalomanatural historynon-functioningpituitary

Autor:innen und Institutionen

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, United Kingdom.
  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TT, United Kingdom.
  • Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2GW, United Kingdom.
  • Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, BT12 6BA, United Kingdom.
  • Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT9 7AE, United Kingdom.
  • Department of Endocrinology and Metabolic Medicine, Royal Stoke University Hospital, University Hospitals of North Midlands, Stoke-on-Trent, ST4 6QE, United Kingdom.

ORCID-Profile: Mark Gurnell, Robert D Murray, Niki Karavitaki

Zitieren

APA

Hamblin, R., Fountas, A., Lithgow, K., Loughrey, P. B., Bonanos, E., Shinwari, S. K., Mitchell, K., Shah, S., Grixti, L., Matheou, M., Isand, K., McLaren, D. S., Surya, A., Ullah, H. Z., Klaucane, K., Jayasuriya, A., Bhatti, S., Mavilakandy, A., Ahsan, M., …, & Karavitaki, N. (2023). Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. European Journal of Endocrinology, 189(1), 87-95. https://doi.org/10.1093/ejendo/lvad070

Vancouver

Hamblin R, Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK, et al. Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. European Journal of Endocrinology. 2023;189(1):87-95. doi:10.1093/ejendo/lvad070

BibTeX
@article{Hamblin2023,
  author = {Hamblin, Ross and Fountas, Athanasios and Lithgow, Kirstie and Loughrey, Paul Benjamin and Bonanos, Efstathios and Shinwari, Shah Khalid and Mitchell, Kirsten and Shah, Syed and Grixti, Lydia and Matheou, Mike and Isand, Kristina and McLaren, David S and Surya, Ashutosh and Ullah, Hafiz Zubair and Klaucane, Katarina and Jayasuriya, Anuradha and Bhatti, Sumbal and Mavilakandy, Akash and Ahsan, Masato and Mathew, Susan and Hussein, Ziad and Jansz, Thijs and Wunna, Wunna and MacFarlane, James and Ayuk, John and Abraham, Prakash and Drake, William M and Gurnell, Mark and Brooke, Antonia and Baldeweg, Stephanie E and Sam, Amir H and Martin, Niamh and Higham, Claire and Reddy, Narendra and Levy, Miles J and Ahluwalia, Rupa and Newell-Price, John and Vamvakopoulos, Joannis and Krishnan, Amutha and Lansdown, Andrew and Murray, Robert D and Pal, Aparna and Bradley, Karin and Mamoojee, Yaasir and Purewal, Tejpal and Panicker, Janki and Freel, E Marie and Hasan, Faisal and Kumar, Mohit and Jose, Biju and Hunter, Steven J and Karavitaki, Niki},
  title = {Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium},
  journal = {European Journal of Endocrinology},
  year = {2023},
  volume = {189},
  number = {1},
  pages = {87--95},
  doi = {10.1093/ejendo/lvad070}
}
Kostenlos starten →